Unique ID issued by UMIN | UMIN000018350 |
---|---|
Receipt number | R000021244 |
Scientific Title | The study of efficacy and safety of laparoscopic gastrectomy for Stage II,III advanced gastric cancer |
Date of disclosure of the study information | 2015/07/19 |
Last modified on | 2020/01/21 20:14:44 |
The study of efficacy and safety of laparoscopic gastrectomy for Stage II,III advanced gastric cancer
The study of efficacy and safety of laparoscopic gastrectomy for Stage II,III advanced gastric cancer
The study of efficacy and safety of laparoscopic gastrectomy for Stage II,III advanced gastric cancer
The study of efficacy and safety of laparoscopic gastrectomy for Stage II,III advanced gastric cancer
Japan |
Gastric cancer
Gastrointestinal surgery |
Malignancy
NO
Inspection of efficacy and safety of laparoscopic gastrectomy for advanced gastric cancer
Efficacy
Overall survival
Achievemnt rate
Background
Procedure
Operation time
Blood loss
Intraoperative complication
Postoperative complication
Postoperative chemotherapy
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Maneuver |
Surgery
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1) Histologically proven gastric carcinoma
2) MP,SS or deeper lesion without involvement of other organs, N0-2 excluding bulky N2 and M0 according to the Japanese classification system
3) tumor located in the upper, body and antrum of the stomach and indication for total or distal gastrectomy
4)No invasion to duodenum
5) Aged 20 to 80 year
6) PS (ECOG)0 or 1
7) Body mass index < 30
8) no history of gastrointestinal surgery
9) no history of chemotherapy or radiotherapy
10) Sufficient organ functions
11) provided written informed consent
1)Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ.
2)Women during pregnancy or breast-feeding.
3)Severe mental disease.
4) Continuous systemic steroid therapy.
5)History of myocardial infarction or unstable angina pectoris within six months.
6)Uncontrollable hypertension.
7)Uncontrollable diabetes millutus or administration of insulin.
8)Severe respiratory disease requiring continuous oxygen therapy.
9)Severe adhesion.
10)Severe circulative disfunction.
11)No resection.
12)The person in charge judges as an inappropriate case.
500
1st name | Akinibu |
Middle name | |
Last name | Taketomi |
Hokkaido University
Gastroenterological Surgery I
060-8638
N15, W7, kita-ku, Sapporo, Japan
011-706-5927
taketomi@med.hokudai.ac.jp
1st name | Tadashi |
Middle name | |
Last name | Yoshida |
Hokkaido University
Gastroenterological Surgery I
060-8638
N15, W7, kita-ku, Sapporo, Japan
011-706-5927
ta73825@dg7.so-net.ne.jp
Gastroenterological Surgery I, Hokkaido University
Self funding
Self funding
Hokkaido University
N15, W7, kita-ku, Sapporo, Japan
011-706-7636
none
NO
2015 | Year | 07 | Month | 19 | Day |
Unpublished
Enrolling by invitation
2015 | Year | 07 | Month | 13 | Day |
2015 | Year | 08 | Month | 01 | Day |
2015 | Year | 08 | Month | 01 | Day |
2021 | Year | 07 | Month | 31 | Day |
2015 | Year | 07 | Month | 19 | Day |
2020 | Year | 01 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021244
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |